17,261 trials
Non-Squamous Non-Small Cell Lung Cancer
Primary: Percentage of Participants Free From Disease Progression or Death at 6 Months — 8.3; 8.1 percentage of participants
Idiopathic Parkinson's Disease
Primary: Mean Change in UPDRS III Score From Baseline in the Meds Off Condition (no Medications) to 26 Weeks Post First Lead Implantation in the Stim on/Meds Off Condition…
Psoriatic Arthritis
Primary: Percentage of ACR Responders Per Treatment at Week 6 — 39; 23; 17; 8 Percentage of ACR responders
Depression
Primary: Depression at Baseline — 27.5; 25.2 units on a scale
Accelerated Phase Chronic Myelogenous Leukemia · Adult Acute Myeloid Leukemia in Remission · Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Primary: The Number of Participants That Experience Grade 2-4 Acute GVHD (Graft Versus Host Disease) by Day 100 — 2 participants
Carotid Artery Stenosis
Primary: Number of Patients With Cerebrovascular Events, Cardiovascular Events or Death. — 0; 2; 2; 1 participants
Aplastic Anemia · Neutropenia · Pancytopenia
Primary: Blood Counts and Adverse Event Profile After 6 Months of Treatment. — 4; 5; 12 participants
Multiple Myeloma
Primary: Myeloma Response Rate Based on the International Myeloma Working Group (IMWG) Uniform Response Criteria — 25.0 percentage of participants responding — p=0.0027
Lymphoma
Primary: Progression-free Survival Rate — 91; 78; 69 percentage of participants
Adult Nasal Type Extranodal NK/T-cell Lymphoma · Anaplastic Large Cell Lymphoma · Angioimmunoblastic T-cell Lymphoma
Primary: Objective Response Rate (ORR) — 2; 6 Participants
Fallopian Tube Cancer · Primary Peritoneal Serous Adenocarcinoma · Recurrent Ovarian Epithelial Cancer
Primary: Clinical Response Benefit (Modified Gynecologic Cancer InterGroup [GCIG] Cancer Antigen [CA]-125 Response or Stable Disease) Based on the Response Evaluation Criteria in…
Duchenne Muscular Dystrophy
Primary: Change in the Number (%) of Dystrophin Positive Fibers — 23; -7.48; 0.79; -0.63 percentage of dystrophin Pos. fibers
Common Cold
Primary: Reducing Symptoms of a Common Cold — 53; 53; 55; 54 units on a scale
Major Depressive Disorder
Primary: Participants With Adverse Events (AEs). — 851; 30 Participants
Meningococcal Meningitis
Primary: Percentages of Subjects With Human Complement Serum Bactericidal Activity (hSBA) Titers ≥ 1:4, After One Dose Of Either MenACWY-CRM(Ad-) or MenACWY-PS Vaccine In…